Literature DB >> 34174373

DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application.

Maoxin Huang1, Shengdi Chen2.   

Abstract

Neurodegenerative diseases (NDs) are one of the major health threats to human characterized by selective and progressive neuronal loss. The mechanisms of NDs are still not fully understood. The study of genetic defects and disease-related proteins offers us a window into the mystery of it, and the extension of knowledge indicates that different NDs share similar features, mechanisms, and even genetic or protein abnormalities. Among these findings, PARK7 and its production DJ-1 protein, which was initially found implicated in PD, have also been found altered in other NDs. PARK7 mutations, altered expression and posttranslational modification (PTM) cause DJ-1 abnormalities, which in turn lead to downstream mechanisms shared by most NDs, such as mitochondrial dysfunction, oxidative stress, protein aggregation, autophagy defects, and so on. The knowledge of DJ-1 derived from PD researches might apply to other NDs in both basic research and clinical application, and might yield novel insights into and alternative approaches for dealing with NDs.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Biomarker; DJ-1; Neurodegenerative diseases; PARK7; Pathogenesis; Therapeutic strategy

Mesh:

Year:  2021        PMID: 34174373     DOI: 10.1016/j.pneurobio.2021.102114

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  6 in total

Review 1.  Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson's Disease.

Authors:  Ezia Guatteo; Nicola Berretta; Vincenzo Monda; Ada Ledonne; Nicola Biagio Mercuri
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Cell-Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson's Disease.

Authors:  Maoxin Huang; Liang Xu; Jin Liu; Pei Huang; Yuyan Tan; Shengdi Chen
Journal:  Front Aging Neurosci       Date:  2022-02-25       Impact factor: 5.750

Review 3.  PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.

Authors:  Domonkos Pap; Apor Veres-Székely; Beáta Szebeni; Ádám Vannay
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

4.  Decoding the Role of Familial Parkinson's Disease-Related Genes in DNA Damage and Repair.

Authors:  Yao-Lin Li; Zhong-Xuan Wang; Chang-Zhou Ying; Bao-Rong Zhang; Jia-Li Pu
Journal:  Aging Dis       Date:  2022-10-01       Impact factor: 9.968

5.  DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila melanogaster.

Authors:  Federica De Lazzari; Francesco Agostini; Davide Doni; Sandro Malacrida; Mauro A Zordan; Paola Costantini; Luigi Bubacco; Federica Sandrelli; Marco Bisaglia
Journal:  Antioxidants (Basel)       Date:  2022-08-05

6.  PARK7 deficiency inhibits fatty acid β-oxidation via PTEN to delay liver regeneration after hepatectomy.

Authors:  Xiaoye Qu; Yankai Wen; Junzhe Jiao; Jie Zhao; Xuehua Sun; Fang Wang; Yueqiu Gao; Weifeng Tan; Qiang Xia; Hailong Wu; Xiaoni Kong
Journal:  Clin Transl Med       Date:  2022-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.